Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyse A Norian

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Immunologic Research|May 20, 2014
Effects of obesity on immune responses to renal tumorsVincent Chehval, Lyse A Norian
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
No intrinsic deficiencies in CD8+ T cell-mediated antitumor immunity with agingLyse A Norian, Paul M Allen
Plos One|September 6, 2007
Rapid maturation of effector T cells in tumors, but not lymphoid organs, during tumor regressionLyse A Norian, Paul M Allen
Frontiers in Immunology|June 29, 2026
Obesity-driven metabolic reprogramming and immune dysfunction in renal cancerHenry N Ogbonna, Lyse A Norian
Frontiers in Immunology|August 23, 2021
Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?Kristine I Farag, Amani Makkouk, Lyse A Norian
Gynecologic Oncology Reports|July 18, 2019
Checkpoint inhibitors in ovarian cancer: A review of preclinical dataDavid W Doo, Lyse A Norian, Rebecca C Arend
Cancers|November 12, 2013
Advances in Viral Vector-Based TRAIL Gene Therapy for CancerLyse A Norian, Britnie R James, Thomas S Griffith
Frontiers in Immunology|July 12, 2019
Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction MimeticsWilliam J Turbitt, Wendy Demark-Wahnefried, Courtney M Peterson, et al.
Gynecologic Oncology|October 19, 2016
Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A reviewEric R Craig, Angelina I Londoño, Lyse A Norian, et al.
Geroscience|October 2, 2020
Diabetes medications as potential calorie restriction mimetics-a focus on the alpha-glucosidase inhibitor acarboseDaniel L Smith, Rachael M Orlandella, David B Allison, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Immunologic Research|May 20, 2014
Effects of obesity on immune responses to renal tumorsVincent Chehval, Lyse A Norian
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
No intrinsic deficiencies in CD8+ T cell-mediated antitumor immunity with agingLyse A Norian, Paul M Allen
Plos One|September 6, 2007
Rapid maturation of effector T cells in tumors, but not lymphoid organs, during tumor regressionLyse A Norian, Paul M Allen
Frontiers in Immunology|June 29, 2026
Obesity-driven metabolic reprogramming and immune dysfunction in renal cancerHenry N Ogbonna, Lyse A Norian
Frontiers in Immunology|August 23, 2021
Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?Kristine I Farag, Amani Makkouk, Lyse A Norian
Gynecologic Oncology Reports|July 18, 2019
Checkpoint inhibitors in ovarian cancer: A review of preclinical dataDavid W Doo, Lyse A Norian, Rebecca C Arend
Cancers|November 12, 2013
Advances in Viral Vector-Based TRAIL Gene Therapy for CancerLyse A Norian, Britnie R James, Thomas S Griffith
Frontiers in Immunology|July 12, 2019
Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction MimeticsWilliam J Turbitt, Wendy Demark-Wahnefried, Courtney M Peterson, et al.
Gynecologic Oncology|October 19, 2016
Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A reviewEric R Craig, Angelina I Londoño, Lyse A Norian, et al.
Geroscience|October 2, 2020
Diabetes medications as potential calorie restriction mimetics-a focus on the alpha-glucosidase inhibitor acarboseDaniel L Smith, Rachael M Orlandella, David B Allison, et al.
Pageof 6